查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1534451

药用玻璃包装市场 - 全球规模、份额、趋势分析、机会、预测，2019-2030

Pharmaceutical Glass Packaging Market - Global Size, Share, Trend Analysis, Opportunity and Forecast, 2019-2030, Segmented By Material; By Route of Administration; By Product; By Drug Type; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2030年全球药用玻璃包装市场规模将突破300亿美元

全球药用玻璃包装市场正在蓬勃发展，生物製药行业对玻璃包装的需求由于其卓越的安全性、可靠性和相容性而迅速增长。

领先的策略咨询和市场研究公司 BlueWeave Consulting 在最近的一项研究中估计，2023 年全球药用玻璃包装市场规模为 195.6 亿美元。 BlueWeave预测，在2024-2030年预测期内，全球药用玻璃包装市场规模将以8.18%的复合年增长率扩大，到2030年将达到300.3亿美元。药用玻璃包装市场是由非专利药注射药物的日益普及和生物製药行业的巨大需求推动的。基于石灰石、碱灰、玻璃屑和沙子的药用玻璃含有钡和锌等必需元素，以提高耐化学性和耐用性。这些特性对于满足严格的製药标准并确保药品安全和包装完整性至关重要。由于疾病盛行率的增加，业界的扩张进一步增加了对可靠玻璃包装的需求。玻璃包装可保护药品免受物理和生物危害并延长保质期。随着该行业的持续成长和技术进步，预计在分析期间药用玻璃包装的需求将激增。

BlueWeave预计2023年全球药用玻璃包装市场规模为682万吨。 BlueWeave预测，在2024-2030年的预测期内，全球药用玻璃包装市场规模将以8.42%的复合年增长率成长，到2030年将达到911万吨。有效的玻璃回收在满足永续药品包装解决方案不断增长的需求方面发挥关键作用。废品回收产业协会强调，再生玻璃可以取代新生产中70%的原料，并增加商业价值。根据Recovery Magazine报道，容器玻璃占年产量1.3亿吨的46%，全球回收率为32%。容器玻璃利用玻璃固有的永续性和材料特性，支持产业转向采用永续实践。

机会－日益关注可回收和生物分解性玻璃材料的开发

玻璃以其永续性和惰性特性而闻名，由于其能够在不发生化学相互作用的情况下保持产品完整性，因此在药品包装中仍然很重要。硼硅酸玻璃和钠钙处理玻璃具有高水解性，适用于多种医疗製剂，包括水溶液和肠胃外药物。玻璃配方和处理技术的进步不断提高耐用性和环境相容性，符合环保解决方案的行业趋势。随着对永续包装替代品的需求增加，可回收和生物分解性玻璃材料的创新有望维持和扩大药品包装市场的成长。

I型材质最常用于药用玻璃包装

全球药用玻璃包装市场由 I 型、II 型和 III 型材料组成。 I型玻璃材料，特别是硼硅酸玻璃，以其出色的耐化学反应性而闻名，非常适合储存需要较强化学耐久性和稳定性的注射药物、注射和製剂。其成分采用硼分子而不是碱金属氧化物，确保了化学惰性和良好的耐受性，使其成为包装各种注射和精细治疗的首选。因此，I类材料在全球药用玻璃包装市场中占最大份额。

地缘政治紧张局势加剧对全球药用玻璃包装市场的影响

不断升级的地缘政治紧张局势可能会对全球药用玻璃包装市场产生多方面的影响。地缘政治不稳定所造成的不确定性可能会危及生产所必需的原材料的供应。贸易壁垒、关税和政治不稳定都会增加成本并扰乱供应链，最终影响市场成长并迫使药品包装产业重新调整定价策略。这些挑战造成了动盪的商业环境，阻碍了市场动态，并削弱了医疗保健行业的国内製造商和国际供应商的成长前景。

竞争格局

全球药用玻璃包装市场较为分散，大量企业进入该市场。主导全球药用玻璃包装市场的主要公司包括康宁公司、尼普罗、山东药用玻璃有限公司、Bormioli Pharma SpA、Owens-Illinois, Inc.、SGD SA、Stoelzle Oberglas GmbH、Gerresheimer AG、West Pharmaceutical Services, Inc.、Piramal Enterprises Ltd、Arab Pharmaceutical Glass Co、Ardagh Group SA、Sisecam Group、Beatson Clark 和DWK Life sciences。每家公司采用​​的主要行销策略是设施扩张、产品多元化、联盟、合作、伙伴关係和收购，以扩大客户范围并获得跨市场的竞争优势。

该报告的详细分析提供了有关全球药用玻璃包装市场的成长潜力、未来趋势和统计数据的资讯。它还涵盖了推动市场总规模预测的因素。该报告致力于提供全球药用玻璃包装市场的最新技术趋势以及业界考察，以帮助决策者做出明智的战略决策。此外，我们也分析了市场的成长动力、挑战和竞争力。

目录

第一章 研究框架

第 2 章执行摘要

第三章全球药用玻璃包装市场洞察

  • 产业价值链分析
  • DROC分析
    • 生长促进因子
      • 不断增长的製药业推动了包装需求
      • 玻璃包装卓越的安全性和可靠性
      • 扩大生技药品市场有利于玻璃的兼容性
    • 抑制因素
      • 与塑胶替代品相比成本较高
      • 在运输和装卸过程中容易损坏
      • 与能源密集型生产相关的环境永续性议题
    • 机会
      • 轻质玻璃配方与处理技术的进步
      • 重点开发可回收或生物分解性的玻璃材料
      • 新兴医药市场的扩张机会
    • 任务
      • 硅砂等原物料价格波动
      • 遵守严格的监管要求
      • 塑胶包装技术进步带来的竞争
  • 科技进步/最新趋势
  • 法律规范
  • 波特五力分析

第四章全球药用玻璃包装市场：行销策略

第五章全球药用玻璃包装市场概况

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 按材质
      • Ⅰ型
      • II型
      • Ⅲ型
    • 依给药途径
      • 口服
      • 胃肠外的
      • 吸入
      • 其他（外用药物）
    • 副产品
      • 管瓶
      • 瓶子
      • 药筒和注射器
      • 安瓿
    • 依药物类型
      • 非专利的
      • 品牌
      • 生物製药
    • 按地区
      • 北美洲
      • 欧洲
      • 亚太地区 (APAC)
      • 拉丁美洲 (LATAM)
      • 中东和非洲（中东/非洲）

第六章北美药用玻璃包装市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 按材质
    • 依给药途径
    • 副产品
    • 依药物类型
    • 按国家/地区
      • 美国
      • 加拿大

第七章欧洲药用玻璃包装市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 按材质
    • 依给药途径
    • 副产品
    • 依药物类型
    • 按国家/地区
      • 德国
      • 英国
      • 义大利
      • 法国
      • 西班牙
      • 比利时
      • 俄罗斯
      • 荷兰
      • 其他欧洲国家

第八章亚太药用玻璃包装市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 按材质
    • 依给药途径
    • 副产品
    • 依药物类型
    • 按国家/地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳洲和纽西兰
      • 印尼
      • 马来西亚
      • 新加坡
      • 越南
      • 亚太地区其他国家

第九章 拉丁美洲药用玻璃包装市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 按材质
    • 依给药途径
    • 副产品
    • 依药物类型
    • 按国家/地区
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘鲁
      • 其他拉丁美洲

第十章中东与非洲药用玻璃包装市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 按材质
    • 依给药途径
    • 副产品
    • 依药物类型
    • 按国家/地区
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 卡达
      • 科威特
      • 南非
      • 奈及利亚
      • 阿尔及利亚
      • 中东和非洲其他地区

第十一章竞争格局

  • 主要企业及其产品列表
  • 2023年全球药用玻璃包装市场占有率分析
  • 透过管理参数进行竞争基准化分析
  • 重大策略发展（合併、收购、联盟等）

第十二章地缘政治紧张局势升级对全球药用玻璃包装市场的影响

第十三章 公司简介（公司简介、财务矩阵、竞争格局、关键人员、主要竞争对手、联络方式、策略展望、SWOT分析）

  • Corning Incorporated
  • Nipro Corporation
  • Shandong Medicinal Glass Co., Ltd
  • Bormioli Pharma SpA
  • Owens-Illinois, Inc.
  • SGD SA
  • Stoelzle Oberglas GmbH
  • Gerresheimer AG
  • West Pharmaceutical Services, Inc.
  • Piramal Enterprises Ltd
  • Arab Pharmaceutical Glass Co.
  • Ardagh Group SA
  • Sisecam Group
  • Beatson Clark
  • DWK Life sciences
  • 其他主要企业

第十四章 主要策略建议

第十五章调查方法

简介目录
Product Code: BWC20292

Global Pharmaceutical Glass Packaging Market Size to Surpass Staggering Value of USD 30 Billion by 2030

Global Pharmaceutical Glass Packaging Market is flourishing because of a spurring demand for glass packaging from the thriving biopharmaceutical industry primarily due to its superior safety, reliability, and compatibility.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Global Pharmaceutical Glass Packaging Market size by value at USD 19.56 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Global Pharmaceutical Glass Packaging Market size to expand at a CAGR of 8.18% reaching a value of USD 30.03 billion by 2030. The Pharmaceutical Glass Packaging Market is propelled by the growing adoption of generic injectable drugs and substantial demand from the biopharmaceutical sector. Pharmaceutical glass, composed primarily of limestone, soda ash, cullet, and sand, incorporates essential elements like barium and zinc to enhance chemical resistance and durability. These properties are crucial for meeting stringent pharmaceutical standards, ensuring drug safety and packaging integrity. The industry's expansion is further fueled by increasing disease prevalence, driving the necessity for reliable glass packaging. The glass packaging shields medications from physical and biological harm while prolonging shelf life. With ongoing sector growth and technological advancements, the demand for pharmaceutical glass packaging is expected to surge during the period in analysis.

By volume, BlueWeave estimated Global Pharmaceutical Glass Packaging Market size at 6.82 million tons in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Global Pharmaceutical Glass Packaging Market size by volume is projected to grow at a CAGR of 8.42% reaching the volume of 9.11 million tons by 2030. Effective glass recycling plays a crucial role in meeting the growing demand for sustainable pharmaceutical packaging solutions. The Institute of Scrap Recycling Industries, Inc., highlights that recycled glass can replace 70% of raw materials in new production, enhancing its commodity value. Container glass constitutes 46% of the annual 130 million tons of glass produced, with a global recycling rate of 32%, as reported by Recovery Magazine. It supports the industry's shift toward adopting sustainable practices, leveraging glass's inherent sustainability and material properties.

Opportunity - Increasing focus on developing recyclable or biodegradable glass materials

Glass, renowned for its sustainability and inert properties, remains crucial in pharmaceutical packaging due to its ability to maintain product integrity without chemical interaction. Types such as borosilicate and treated soda-lime glass offer high hydrolytic resistance and suitability for various medical preparations, including aqueous solutions and parenteral medications. Advances in glass formulation and treatment technologies continue to improve durability and environmental compatibility, aligning with industry trends towards eco-friendly solutions. As the demand grows for sustainable packaging alternatives, innovations in recyclable and biodegradable glass materials promise to sustain and expand market growth in pharmaceutical packaging.

Type I Material Most Used in Pharmaceutical Glass Packaging

Global Pharmaceutical Glass Packaging Market comprises Type I, Type II, and Type III material segments. Type I glass material, particularly borosilicate glass, is renowned for its outstanding resistance to chemical reactions, making it highly suitable for preserving parenteral drugs, injectables, and formulations that demand robust chemical durability and stability. Its composition, incorporating boron molecules instead of alkaline oxides, ensures chemical inertness and superior resistance, making it the preferred option for packaging a diverse array of injectables and sensitive treatments. Hence, the type I material segment holds the largest share in Global Pharmaceutical Glass Packaging Market.

Impact of Escalating Geopolitical Tensions on Global Pharmaceutical Glass Packaging Market

Intensifying geopolitical tensions can have a multifaceted impact on Global Pharmaceutical Glass Packaging Market. Uncertainties stemming from geopolitical instability can jeopardize the availability of raw materials crucial for production. Trade barriers, tariffs, and political instability can all inflate costs and fracture supply chains, ultimately impacting market growth and forcing a recalibration of pricing strategies within the pharmaceutical packaging sector. These challenges converge to create a turbulent business environment, hindering market dynamics and dampening growth prospects for both domestic manufacturers and international suppliers operating within the healthcare sector.

Competitive Landscape

Global Pharmaceutical Glass Packaging Market is fragmented, with numerous players serving the market. The key players dominating Global Pharmaceutical Glass Packaging Market include Corning Incorporated, Nipro Corporation, Shandong Medicinal Glass Co., Ltd, Bormioli Pharma S.p.A., Owens-Illinois, Inc., SGD S.A., Stoelzle Oberglas GmbH, Gerresheimer AG, West Pharmaceutical Services, Inc., Piramal Enterprises Ltd, Arab Pharmaceutical Glass Co., Ardagh Group S.A., Sisecam Group, Beatson Clark, and DWK Life sciences. The key marketing strategies adopted by the players are facility expansion, product diversification, alliances, collaborations, partnerships, and acquisitions to expand their customer reach and gain a competitive edge in the overall market.

The report's in-depth analysis provides information about growth potential, upcoming trends, and Global Pharmaceutical Glass Packaging Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Pharmaceutical Glass Packaging Market along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Pharmaceutical Glass Packaging Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Growing pharmaceutical industry driving demand for packaging
      • 3.2.1.2. Superior safety and reliability of glass packaging
      • 3.2.1.3. Increasing market for biologics favoring glass due to compatibility
    • 3.2.2. Restraints
      • 3.2.2.1. Higher cost compared to plastic alternatives
      • 3.2.2.2. Susceptibility to breakage during transportation and handling
      • 3.2.2.3. Environmental sustainability concerns related to energy-intensive production
    • 3.2.3. Opportunities
      • 3.2.3.1. Advancements in lightweight glass formulations and handling technologies
      • 3.2.3.2. Focus on developing recyclable or biodegradable glass materials
      • 3.2.3.3. Expansion opportunities in emerging pharmaceutical markets
    • 3.2.4. Challenges
      • 3.2.4.1. Volatility in raw material prices, such as silica sand
      • 3.2.4.2. Compliance with stringent regulatory requirements
      • 3.2.4.3. Competition from advancing plastic packaging technologies
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Pharmaceutical Glass Packaging Market: Marketing Strategies

5. Global Pharmaceutical Glass Packaging Market Overview

  • 5.1. Market Size & Forecast, 2019-2030
    • 5.1.1. By Value (USD Billion)
  • 5.2. Market Share and Forecast
    • 5.2.1. By Material
      • 5.2.1.1. Type I
      • 5.2.1.2. Type II
      • 5.2.1.3. Type III
    • 5.2.2. By Route of Administration
      • 5.2.2.1. Oral
      • 5.2.2.2. Parenteral
      • 5.2.2.3. Inhalation
      • 5.2.2.4. Others (Topical etc.)
    • 5.2.3. By Product
      • 5.2.3.1. Vials
      • 5.2.3.2. Bottles
      • 5.2.3.3. Cartridges & Syringes
      • 5.2.3.4. Ampoules
    • 5.2.4. By Drug Type
      • 5.2.4.1. Generic
      • 5.2.4.2. Branded
      • 5.2.4.3. Biologics
    • 5.2.5. By Region
      • 5.2.5.1. North America
      • 5.2.5.2. Europe
      • 5.2.5.3. Asia Pacific (APAC)
      • 5.2.5.4. Latin America (LATAM)
      • 5.2.5.5. Middle East and Africa (MEA)

6. North America Pharmaceutical Glass Packaging Market

  • 6.1. Market Size & Forecast, 2019-2030
    • 6.1.1. By Value (USD Billion)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Material
    • 6.2.2. By Route of Administration
    • 6.2.3. By Product
    • 6.2.4. By Drug Type
    • 6.2.5. By Country
      • 6.2.5.1. United States
      • 6.2.5.1.1. By Material
      • 6.2.5.1.2. By Route of Administration
      • 6.2.5.1.3. By Product
      • 6.2.5.1.4. By Drug Type
      • 6.2.5.2. Canada
      • 6.2.5.2.1. By Material
      • 6.2.5.2.2. By Route of Administration
      • 6.2.5.2.3. By Product
      • 6.2.5.2.4. By Drug Type

7. Europe Pharmaceutical Glass Packaging Market

  • 7.1. Market Size & Forecast, 2019-2030
    • 7.1.1. By Value (USD Billion)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Material
    • 7.2.2. By Route of Administration
    • 7.2.3. By Product
    • 7.2.4. By Drug Type
    • 7.2.5. By Country
      • 7.2.5.1. Germany
      • 7.2.5.1.1. By Material
      • 7.2.5.1.2. By Route of Administration
      • 7.2.5.1.3. By Product
      • 7.2.5.1.4. By Drug Type
      • 7.2.5.2. United Kingdom
      • 7.2.5.2.1. By Material
      • 7.2.5.2.2. By Route of Administration
      • 7.2.5.2.3. By Product
      • 7.2.5.2.4. By Drug Type
      • 7.2.5.3. Italy
      • 7.2.5.3.1. By Material
      • 7.2.5.3.2. By Route of Administration
      • 7.2.5.3.3. By Product
      • 7.2.5.3.4. By Drug Type
      • 7.2.5.4. France
      • 7.2.5.4.1. By Material
      • 7.2.5.4.2. By Route of Administration
      • 7.2.5.4.3. By Product
      • 7.2.5.4.4. By Drug Type
      • 7.2.5.5. Spain
      • 7.2.5.5.1. By Material
      • 7.2.5.5.2. By Route of Administration
      • 7.2.5.5.3. By Product
      • 7.2.5.5.4. By Drug Type
      • 7.2.5.6. Belgium
      • 7.2.5.6.1. By Material
      • 7.2.5.6.2. By Route of Administration
      • 7.2.5.6.3. By Product
      • 7.2.5.6.4. By Drug Type
      • 7.2.5.7. Russia
      • 7.2.5.7.1. By Material
      • 7.2.5.7.2. By Route of Administration
      • 7.2.5.7.3. By Product
      • 7.2.5.7.4. By Drug Type
      • 7.2.5.8. The Netherlands
      • 7.2.5.8.1. By Material
      • 7.2.5.8.2. By Route of Administration
      • 7.2.5.8.3. By Product
      • 7.2.5.8.4. By Drug Type
      • 7.2.5.9. Rest of Europe
      • 7.2.5.9.1. By Material
      • 7.2.5.9.2. By Route of Administration
      • 7.2.5.9.3. By Product
      • 7.2.5.9.4. By Drug Type

8. Asia Pacific Pharmaceutical Glass Packaging Market

  • 8.1. Market Size & Forecast, 2019-2030
    • 8.1.1. By Value (USD Billion)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Material
    • 8.2.2. By Route of Administration
    • 8.2.3. By Product
    • 8.2.4. By Drug Type
    • 8.2.5. By Country
      • 8.2.5.1. China
      • 8.2.5.1.1. By Material
      • 8.2.5.1.2. By Route of Administration
      • 8.2.5.1.3. By Product
      • 8.2.5.1.4. By Drug Type
      • 8.2.5.2. India
      • 8.2.5.2.1. By Material
      • 8.2.5.2.2. By Route of Administration
      • 8.2.5.2.3. By Product
      • 8.2.5.2.4. By Drug Type
      • 8.2.5.3. Japan
      • 8.2.5.3.1. By Material
      • 8.2.5.3.2. By Route of Administration
      • 8.2.5.3.3. By Product
      • 8.2.5.3.4. By Drug Type
      • 8.2.5.4. South Korea
      • 8.2.5.4.1. By Material
      • 8.2.5.4.2. By Route of Administration
      • 8.2.5.4.3. By Product
      • 8.2.5.4.4. By Drug Type
      • 8.2.5.5. Australia & New Zealand
      • 8.2.5.5.1. By Material
      • 8.2.5.5.2. By Route of Administration
      • 8.2.5.5.3. By Product
      • 8.2.5.5.4. By Drug Type
      • 8.2.5.6. Indonesia
      • 8.2.5.6.1. By Material
      • 8.2.5.6.2. By Route of Administration
      • 8.2.5.6.3. By Product
      • 8.2.5.6.4. By Drug Type
      • 8.2.5.7. Malaysia
      • 8.2.5.7.1. By Material
      • 8.2.5.7.2. By Route of Administration
      • 8.2.5.7.3. By Product
      • 8.2.5.7.4. By Drug Type
      • 8.2.5.8. Singapore
      • 8.2.5.8.1. By Material
      • 8.2.5.8.2. By Route of Administration
      • 8.2.5.8.3. By Product
      • 8.2.5.8.4. By Drug Type
      • 8.2.5.9. Vietnam
      • 8.2.5.9.1. By Material
      • 8.2.5.9.2. By Route of Administration
      • 8.2.5.9.3. By Product
      • 8.2.5.9.4. By Drug Type
      • 8.2.5.10. Rest of APAC
      • 8.2.5.10.1. By Material
      • 8.2.5.10.2. By Route of Administration
      • 8.2.5.10.3. By Product
      • 8.2.5.10.4. By Drug Type

9. Latin America Pharmaceutical Glass Packaging Market

  • 9.1. Market Size & Forecast, 2019-2030
    • 9.1.1. By Value (USD Billion)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Material
    • 9.2.2. By Route of Administration
    • 9.2.3. By Product
    • 9.2.4. By Drug Type
    • 9.2.5. By Country
      • 9.2.5.1. Brazil
      • 9.2.5.1.1. By Material
      • 9.2.5.1.2. By Route of Administration
      • 9.2.5.1.3. By Product
      • 9.2.5.1.4. By Drug Type
      • 9.2.5.2. Mexico
      • 9.2.5.2.1. By Material
      • 9.2.5.2.2. By Route of Administration
      • 9.2.5.2.3. By Product
      • 9.2.5.2.4. By Drug Type
      • 9.2.5.3. Argentina
      • 9.2.5.3.1. By Material
      • 9.2.5.3.2. By Route of Administration
      • 9.2.5.3.3. By Product
      • 9.2.5.3.4. By Drug Type
      • 9.2.5.4. Peru
      • 9.2.5.4.1. By Material
      • 9.2.5.4.2. By Route of Administration
      • 9.2.5.4.3. By Product
      • 9.2.5.4.4. By Drug Type
      • 9.2.5.5. Rest of LATAM
      • 9.2.5.5.1. By Material
      • 9.2.5.5.2. By Route of Administration
      • 9.2.5.5.3. By Product
      • 9.2.5.5.4. By Drug Type

10. Middle East & Africa Pharmaceutical Glass Packaging Market

  • 10.1. Market Size & Forecast, 2019-2030
    • 10.1.1. By Value (USD Billion)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Material
    • 10.2.2. By Route of Administration
    • 10.2.3. By Product
    • 10.2.4. By Drug Type
    • 10.2.5. By Country
      • 10.2.5.1. Saudi Arabia
      • 10.2.5.1.1. By Material
      • 10.2.5.1.2. By Route of Administration
      • 10.2.5.1.3. By Product
      • 10.2.5.1.4. By Drug Type
      • 10.2.5.2. UAE
      • 10.2.5.2.1. By Material
      • 10.2.5.2.2. By Route of Administration
      • 10.2.5.2.3. By Product
      • 10.2.5.2.4. By Drug Type
      • 10.2.5.3. Qatar
      • 10.2.5.3.1. By Material
      • 10.2.5.3.2. By Route of Administration
      • 10.2.5.3.3. By Product
      • 10.2.5.3.4. By Drug Type
      • 10.2.5.4. Kuwait
      • 10.2.5.4.1. By Material
      • 10.2.5.4.2. By Route of Administration
      • 10.2.5.4.3. By Product
      • 10.2.5.4.4. By Drug Type
      • 10.2.5.5. South Africa
      • 10.2.5.5.1. By Material
      • 10.2.5.5.2. By Route of Administration
      • 10.2.5.5.3. By Product
      • 10.2.5.5.4. By Drug Type
      • 10.2.5.6. Nigeria
      • 10.2.5.6.1. By Material
      • 10.2.5.6.2. By Route of Administration
      • 10.2.5.6.3. By Product
      • 10.2.5.6.4. By Drug Type
      • 10.2.5.7. Algeria
      • 10.2.5.7.1. By Material
      • 10.2.5.7.2. By Route of Administration
      • 10.2.5.7.3. By Product
      • 10.2.5.7.4. By Drug Type
      • 10.2.5.8. Rest of MEA
      • 10.2.5.8.1. By Material
      • 10.2.5.8.2. By Route of Administration
      • 10.2.5.8.3. By Product
      • 10.2.5.8.4. By Drug Type

11. Competitive Landscape

  • 11.1. List of Key Players and Their Offerings
  • 11.2. Global Pharmaceutical Glass Packaging Market Share Analysis, 2023
  • 11.3. Competitive Benchmarking, By Operating Parameters
  • 11.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

12. Impact of Escalating Geopolitical Tensions on Global Pharmaceutical Glass Packaging Market

13. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

  • 13.1. Corning Incorporated
  • 13.2. Nipro Corporation
  • 13.3. Shandong Medicinal Glass Co., Ltd
  • 13.4. Bormioli Pharma S.p.A.
  • 13.5. Owens-Illinois, Inc.
  • 13.6. SGD S.A.
  • 13.7. Stoelzle Oberglas GmbH
  • 13.8. Gerresheimer AG
  • 13.9. West Pharmaceutical Services, Inc.
  • 13.10. Piramal Enterprises Ltd
  • 13.11. Arab Pharmaceutical Glass Co.
  • 13.12. Ardagh Group S.A.
  • 13.13. Sisecam Group
  • 13.14. Beatson Clark
  • 13.15. DWK Life sciences
  • 13.16. Other Prominent Players

14. Key Strategic Recommendations

15. Research Methodology

  • 15.1. Qualitative Research
    • 15.1.1. Primary & Secondary Research
  • 15.2. Quantitative Research
  • 15.3. Market Breakdown & Data Triangulation
    • 15.3.1. Secondary Research
    • 15.3.2. Primary Research
  • 15.4. Breakdown of Primary Research Respondents, By Region
  • 15.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable